| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.008 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0023 | 1 |